(1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione

C39H41BrN6O4 — CID 158045485

IUPAC(1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione
SMILESCC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCC=CCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/C39H41BrN6O4/c1-23-11-12-35(40)43-31(23)17-33(49)32-18-39-14-13-29(48)10-8-6-4-5-7-9-26-15-27(28-20-41-25(3)42-21-28)16-30-37(24(2)47)44-45(38(26)30)22-36(50)46(32)34(39)19-39/h4-5,11-12,15-16,20-21,32,34H,6-10,13-14,17-19,22H2,1-3H3/t32-,34+,39-/m0/s1
InChIKeySGHYPTRLGRMWFD-DECSONGXSA-N
MW737.70 g/mol
LogP6.66
Rot. Bonds5

About (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione

(1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione (PubChem CID 158045485) has the molecular formula C39H41BrN6O4 and a molecular weight of 737.70 g/mol. Its IUPAC name is (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione.

Molecular Properties

Compound Name(1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione
PubChem CID158045485
Molecular FormulaC39H41BrN6O4
Molecular Weight737.70 g/mol
Exact Mass736.24
IUPAC Name(1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione
SMILESCC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCC=CCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/C39H41BrN6O4/c1-23-11-12-35(40)43-31(23)17-33(49)32-18-39-14-13-29(48)10-8-6-4-5-7-9-26-15-27(28-20-41-25(3)42-21-28)16-30-37(24(2)47)44-45(38(26)30)22-36(50)46(32)34(39)19-39/h4-5,11-12,15-16,20-21,32,34H,6-10,13-14,17-19,22H2,1-3H3/t32-,34+,39-/m0/s1
InChIKeySGHYPTRLGRMWFD-DECSONGXSA-N
XLogP6.66
TPSA128.01 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500737.70
LogP ≤ 56.66
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione?
The IUPAC name of (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione (CID 158045485) is (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione.
What is the SMILES notation for (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione?
The canonical SMILES for (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione is CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCC=CCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(Br)ccc4C)N(C(=O)C2)[C@@H]1C3.
What is the InChIKey of (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione?
The InChIKey is SGHYPTRLGRMWFD-DECSONGXSA-N. The full InChI is InChI=1S/C39H41BrN6O4/c1-23-11-12-35(40)43-31(23)17-33(49)32-18-39-14-13-29(48)10-8-6-4-5-7-9-26-15-27(28-20-41-25(3)42-21-28)16-30-37(24(2)47)44-45(38(26)30)22-36(50)46(32)34(39)19-39/h4-5,11-12,15-16,20-21,32,34H,6-10,13-14,17-19,22H2,1-3H3/t32-,34+,39-/m0/s1.
What are the key properties of (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione?
(1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione has a molecular weight of 737.70 g/mol, XLogP of 6.66, 5 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,23R,26S)-17-acetyl-26-[2-(6-bromo-3-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-8,12(27),13,15,17-pentaene-4,21-dione is sourced from PubChem (CID 158045485), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).